[PharmaEssentia] Update on Progress of the Petition to Set Aside Arbitration Award
PharmaEssentia announced that the Higher Regional Court of Frankfurt dismissed its petition to set aside a partial arbitration award in its dispute with AOP. The company will appeal to the Federal Court of Justice.
📋 Article Processing Timeline
- 📰 Published: April 24, 2026 at 09:00
- 🔍 Collected: April 27, 2026 at 08:00 (71h 0m after Published)
- 🤖 AI Analyzed: April 27, 2026 at 08:02 (2 min after Collected)
1. Parties to the legal event:
Petitioner: PharmaEssentia Corp.
Respondent: AOP Orphan Pharmaceuticals GmbH (AOP).
2. Name of the court or disciplinary authority: Higher Regional Court of Frankfurt, Germany.
3. Case number: 32 Sch 5/25.
4. Date of occurrence: April 24, 2026.
5. Reason (including subject matter of litigation):
Regarding the arbitration case between the Company and AOP, the Company received a Partial Final Award from the International Court of Arbitration of the International Chamber of Commerce (ICC) on February 17, 2025. The Company filed a petition to set aside a portion of the partial final award with the Higher Regional Court of Frankfurt according to the law. On April 24, 2026, the Higher Regional Court of Frankfurt dismissed the Company's petition.
6. Handling process:
This ruling is not a final decision. The Company will file an appeal with the German Federal Court of Justice and continue to engage lawyers to handle subsequent procedures.
7. Impact on company finances and business and estimated impact amount:
This ruling has no impact on the Company's current financial and business status, as it only involves whether part of the arbitration award should be set aside and is not a final judgment.
8. Response measures and improvements:
In response to the Frankfurt court's ruling, the Company will appeal to the German Federal Court of Justice, citing that core legal claims and important evidence were not properly reviewed under the law.
9. Other matters to be stated: None.
Petitioner: PharmaEssentia Corp.
Respondent: AOP Orphan Pharmaceuticals GmbH (AOP).
2. Name of the court or disciplinary authority: Higher Regional Court of Frankfurt, Germany.
3. Case number: 32 Sch 5/25.
4. Date of occurrence: April 24, 2026.
5. Reason (including subject matter of litigation):
Regarding the arbitration case between the Company and AOP, the Company received a Partial Final Award from the International Court of Arbitration of the International Chamber of Commerce (ICC) on February 17, 2025. The Company filed a petition to set aside a portion of the partial final award with the Higher Regional Court of Frankfurt according to the law. On April 24, 2026, the Higher Regional Court of Frankfurt dismissed the Company's petition.
6. Handling process:
This ruling is not a final decision. The Company will file an appeal with the German Federal Court of Justice and continue to engage lawyers to handle subsequent procedures.
7. Impact on company finances and business and estimated impact amount:
This ruling has no impact on the Company's current financial and business status, as it only involves whether part of the arbitration award should be set aside and is not a final judgment.
8. Response measures and improvements:
In response to the Frankfurt court's ruling, the Company will appeal to the German Federal Court of Justice, citing that core legal claims and important evidence were not properly reviewed under the law.
9. Other matters to be stated: None.